UL Solutions director receives RSU and DRSU awards
KENNEDY KEVIN reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
KENNEDY KEVIN reported acquisition or exercise transactions in this Form 4 filing.
UL Solutions Inc. director Kevin Kennedy reported routine equity compensation awards tied to his existing stock units. On June 8, 2026, he received 3 Restricted Stock Units (RSUs) and 4 and 7 Deferred Restricted Stock Units (DRSUs), each representing a right to one share of Class A Common Stock.
The RSU and DRSU entries primarily reflect the accrual of dividend equivalent rights on awards he already holds, rather than new open-market purchases. After these grants, his reported direct holdings include 2,209 RSUs and 4,969 DRSUs, which will settle in Class A shares under UL Solutions’ non-employee director deferred compensation framework.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Deferred Restricted Stock Units | 7 | $0.00 | $0.00 |
| Grant/Award | Deferred Restricted Stock Units | 4 | $0.00 | $0.00 |
| Grant/Award | Restricted Stock Units | 3 | $0.00 | $0.00 |
Footnotes (8)
- F1. Each restricted stock unit ("RSU") and deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- F2. Represents accrual of dividend equivalent rights on DRSUs held by the Reporting Person.
- F3. The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vested on May 1, 2025, and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Non-Employee Director Deferred Compensation Plan (the "Plan"), or (ii) as otherwise provided by the Plan.
- F4. Includes DRSUs and all dividend equivalent rights that have accrued on such DRSUs to date.
- F5. The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vested on May 20, 2026, and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Plan, or (ii) as otherwise provided by the Plan.
- F6. Represents accrual of dividend equivalent rights on RSUs held by the Reporting Person.
- F7. The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest on the earlier of May 20, 2027, or the date of the annual meeting following the May 20, 2026, grant date.
- F8. Includes RSUs and all dividend equivalent rights that have accrued on such RSUs to date.
Key Figures
Key Terms
Restricted Stock Units financial
Deferred Restricted Stock Units financial
dividend equivalent rights financial
Non-Employee Director Deferred Compensation Plan financial
vesting financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did UL Solutions (ULS) director Kevin Kennedy report in this Form 4?
How many RSUs and DRSUs did Kevin Kennedy acquire in the latest UL Solutions (ULS) filing?
Are Kevin Kennedy’s UL Solutions (ULS) transactions open-market stock purchases or sales?
What do UL Solutions (ULS) RSUs and DRSUs represent for Kevin Kennedy?
When do Kevin Kennedy’s UL Solutions (ULS) DRSUs and RSUs vest and settle?
How many UL Solutions (ULS) stock units does Kevin Kennedy hold after these awards?
AI-generated analysis. How Rhea-AI works. Not financial advice.